You are here

Vitae

Allergan: How Will the Purchase of Vitae Pharmaceuticals Inc Affect it?

Allergan: How Will the Purchase of Vitae Pharmaceuticals Inc Affect it?

Bidness, ETC

Flag link:

Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million

Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million

Marketwatch

autoimmune disease

Flag link:

4 Key Biopharma Movers of the Past Week

4 Key Biopharma Movers of the Past Week

24/7 Wall St

Bio Blast Pharma

Flag link:

3 Top Biopharma Movers of the Past Week

3 Top Biopharma Movers of the Past Week

24/7 Wall St

Juno Therapeutics

Flag link:

Vitae tanks after cutting its psoriasis trial short, stoking safety concerns

Vitae tanks after cutting its psoriasis trial short, stoking safety concerns

Fierce Biotech

clinical trials

Flag link:

Biotechs Coming Off One Of The Busiest Weeks In Recent Memory

Biotechs Coming Off One Of The Busiest Weeks In Recent Memory

Yahoo/Benzinga

Gilead Sciences

Clovis Oncology

Bristol-Myers Squibb

Tetraphase Pharmaceuticals

Flag link:

This Past Week’s Top 5 Biotech Movers

This Past Week’s Top 5 Biotech Movers

24/7 Wall St

Akebia Therapeutics

Clovis Oncology

Mirati Therapeutics

Flag link:

Vitae and Boehringer Get on BACE

Vitae and Boehringer Get on BACE

InVivo

Boehringer Ingelheim

Alzheimer's disease

Flag link: